Lv62
2912 积分 2024-04-24 加入
Targeted β‐Glucan‐Veiled Oral Apremilast Nanotherapy Modulates Key Dysbiosis‐Associated Gut Microbiota and Alleviates Ulcerative Colitis‐Associated Anxiety, Depression, and Neuropsychiatric Behaviors
1天前
已完结
In vitro assessment of probiotic and functional properties of Bacillus coagulans T242
9天前
已完结
The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases
11天前
已完结
Discovery of selective JAK1/2 inhibitor H018, a phase II agent with demonstrated preclinical anti-rheumatoid arthritis activity
11天前
已完结
Bioinspired yeast-based β-glucan system for oral drug delivery
11天前
已完结
Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems
11天前
已完结
Targeting the gut–joint axis: an oral Spirulina hydrogel as an adjuvant strategy for rheumatoid arthritis therapy
26天前
已完结
The gut-enthesis axis and the pathogenesis of Spondyloarthritis
26天前
已完结
Oral Nanomedicine: Challenges and Opportunities
26天前
已完结
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease
26天前
已完结
皖公网安备34019202002308
